Jordan Goldstein, MD, MSc¹, Won Seog Kim, MD, MPH, PhD^2*, Sang Eun Yoon^3*, Seok Jin Kim, MD, PhD⁴, Mark Roschewski, MD⁵, Jason Westin, MD⁶, Ryan C Lynch, MD⁷, Stefan K. Alig, MD⁸, Sandra Close, PhD^9*, Jacob J. Chabon, PhD^9*, Davide Rossi¹⁰, Wyndham H Wilson, MD, PhD^5*, Maximilian Diehn, MD, PhD^11*, Ash A. Alizadeh, MD, PhD⁸ and David M. Kurtz, MD, PhD⁸

¹Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Palo Alto, CA
²Samsung Medical Center, Center for Hematologic Malignancy, Seoul, Korea, Republic of (South)
³Samsung Medical Center, Seoul, KOR
⁴Samsung Med. Ctr., Seoul, Korea, Republic of (South)
⁵Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁶Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX
⁷Division of Hematology and Oncology, University of Washington, Seattle, WA
⁸Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁹Foresight Diagnostics, Aurora, CO
¹⁰Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
¹¹Department of Radiation Oncology, Stanford University, Stanford, CA

Jinhua Liang, MD, PhD^1*, Yi-fan Wu, MD^1*, Hao-Rui Shen, MD, PhD^1*, Yue Li, MD, PhD^1*, Jun-heng Liang, MD^2*, Xin-Yu Zhang, MD, PhD^1*, Sibusiso Luthuli, MD^1*, Jiazhu Wu, MD, PhD^1*, Liu qing Zhu, MD, PhD^2*, Hua Yin, MD, PhD^1*, Li Wang, MD, PhD^1*, Jianyong Li, MD³ and Xu Wei, MD, PhD⁴

¹Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
²Nanjing Geneseeq Technology Inc., Nanjing, China
³Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁴Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing City, Jiangsu Province, China

Han Zhang^1*, Lingfeng Liu^2*, Xingping Lang^2*, Sheng Xiao^3* and Bingzong Li, MD, PhD¹

¹The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
²Suzhou Sano Precision Medicine, Suzhou, China
³Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Jelena Jelicic^1,2*, Karen Juul-Jensen^1*, Zoran Bukumiric^3*, Michael Roost Clausen, MD, PhD^2*, Ahmed Ludvigsen Al-Mashhadi^4,5*, Robert Schou Pedersen^6*, Christian Bjørn Poulsen^7*, Peter de Nully Brown, MD, PhD⁸, Tarec Christoffer Christoffer El-Galaly, MD, DSc^9,10 and Thomas Stauffer Larsen^9*

¹Department of Hematology, Odense University Hospital, Odense, Denmark, Odense, Denmark
²Department of Hematology, Vejle Hospital, Sygehus Lillebaelt, Vejle, Denmark, Vejle, Denmark
³Institute for Medical Statistics and Informatics, University of Belgrade, Faculty of Medicine, Belgrade, Serbia
⁴Department of Hematology, Aarhus University Hospital, Aarhus, Denmark, Aarhus, Denmark
⁵Department of Hematology, Aalborg University Hospital, Viborg, Denmark
⁶Gødstrup Hospital, Herning, Denmark
⁷Department of Hematology, Zealand University Hospital, Roskilde, Denmark
⁸Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Denmark, Copenhagen, Denmark
⁹Department of Hematology, Odense University Hospital, Odense, Denmark
¹⁰Department of Hematology, Aalborg University Hospital, Aalborg, Denmark

Marita Ziepert, PhD^1*, Bettina Altmann, PhD^1*, Viola Poeschel, MD^2*, Caterina Cristinelli^3*, Loïc Chartier^4*, Nicolas Ketterer, MD^5*, Christian Recher, MD, PhD^6*, Olivier Fitoussi^7*, Gerhard Held^8*, Olivier Casasnovas, MD^9*, Corinne Haioun, MD, PhD¹⁰, Nicolas Mounier^11*, Hervé Tilly, MD¹², Franck Morschhauser, MD PhD^13*, Andreas Rosenwald, MD^14*, German Ott, MD^15*, Thierry Jo Molina, MD, PhD^16*, Georg Lenz¹⁷, Catherine Thieblemont, MD^3* and Norbert Schmitz^17*

¹Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany
²Department of Internal Medicine 1, Oncology, Hematology, Clinical Immunology, and Rheumatology, Saarland University Medical Center, Homburg/Saar, Germany
³Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Université de Paris, Paris, France
⁴LYSARC, Pierre Bénite, France
⁵Clinique Bois-Cerf, Lausanne, CHE
⁶Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
⁷Oncologie-Hematologie, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, FRA
⁸Department for Hematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany
⁹Department of Hematology, Centre Hospitalier Universitaire Dijon, Dijon, France
¹⁰Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
¹¹CHU De Nice, Hôpital De L Archet, Nice, France
¹²Centre Henri-Becquerel and University of Rouen, Rouen, France
¹³Centre Hospitalier Universitaire (CHU) Lille, Lille, France
¹⁴Institute of Pathology, Julius-Maximilians-Universität Würzburg, Wuerzburg, Germany
¹⁵Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
¹⁶Necker enfants malades, APHP, Paris, Paris, France
¹⁷Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany

Mark Roschewski, MD¹, Liza Lindenberg, MD^2*, Esther Mena, MD^2*, Rahul Lakhotia, MBBS¹, Christopher Melani, MD¹, Seth M. Steinberg, PhD^3*, Andre Schultz, PhD^4*, Gregory Hogan, PhD^4*, Jake J. Chabon, PhD^4*, Sandra Close, PhD^4*, Maximilian Diehn, MD, PhD^5*, Brian J. Sworder, MD, PhD⁶, David M. Kurtz, MD, PhD⁷, Ash A. Alizadeh, MD, PhD⁷ and Wyndham H. Wilson, MD, PhD^1*

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Foresight Diagnostics, Aurora, CO
⁵Department of Radiation Oncology, Stanford University, Stanford, CA
⁶Division of Oncology, Department of Medicine, Stanford University, Irvine, CA
⁷Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA